Human Genome Epidemiology Literature Finder
|
Records 1 - 15 (of 15 Records) |
| Query Trace: Leukemia and UGT1A1[original query] |
|---|
| Effects of prednisone and genetic polymorphisms on etoposide disposition in children with acute lymphoblastic leukemia. Blood 2004 Jan 103 (1): 67-72. Kishi Shinji, Yang Wenjian, Boureau Benoit, Morand Stanislas, Das Soma, Chen Peixian, Cook Edwin H, Rosner Gary L, Schuetz Erin, Pui Ching-Hon, Relling Mary |
| Global gene expression as a function of germline genetic variation. Human molecular genetics 2005 Jun 14 (12): 1621-9. French Deborah, Wilkinson Mark R, Yang Wenjian, de Chaisemartin Luc, Cook Edwin H, Das Soma, Ratain Mark J, Evans William E, Downing James R, Pui Ching-Hon, Relling Mary |
| UGT1A1 promoter polymorphism increases risk of nilotinib-induced hyperbilirubinemia. Leukemia 2007 Nov 21 (11): 2311-5. Singer J B, Shou Y, Giles F, Kantarjian H M, Hsu Y, Robeva A S, Rae P, Weitzman A, Meyer J M, Dugan M, Ottmann O |
| Genotyping panel for assessing response to cancer chemotherapy. BMC medical genomics 2008 Jun 1 (1): 24. Dai Z, Papp AC, Wang D, Hampel H, Sadee W |
| Flavopiridol pharmacogenetics: clinical and functional evidence for the role of SLCO1B1/OATP1B1 in flavopiridol disposition. PloS one 2010 5 (11): e13792. Ni Wenjun, Ji Jia, Dai Zunyan, Papp Audrey, Johnson Amy J, Ahn Sunjoo, Farley Katherine L, Lin Thomas S, Dalton James T, Li Xiaobai, Jarjoura David, Byrd John C, Sadee Wolfgang, Grever Michael R, Phelps Mitch |
| Association between severe toxicity of nilotinib and UGT1A1 polymorphisms in Japanese patients with chronic myelogenous leukemia. International journal of clinical oncology 2014 Apr 19 (2): 391-6. Shibata Takashi, Minami Yosuke, Mitsuma Ayako, Morita Sachi, Inada-Inoue Megumi, Oguri Tomoyo, Shimokata Tomoya, Sugishita Mihoko, Naoe Tomoki, Ando Yuic |
| UGT1A1*28 polymorphism and acute lymphoblastic leukemia in children: a Danish case-control study. Pediatric research 2014 Nov 76 (5): 459-63. Petersen Jesper P, Overvad Kim, Hollegaard Mads V, Ebbesen Finn, Henriksen Tine B, Thorlacius-Ussing Ole, Hougaard David M, Schrøder Henr |
| Influence of UGT1A1 6, 27, and 28 polymorphisms on nilotinib-induced hyperbilirubinemia in Japanese patients with chronic myeloid leukemia. Drug metabolism and pharmacokinetics 2014 29 (6): 449-54. Abumiya Maiko, Takahashi Naoto, Niioka Takenori, Kameoka Yoshihiro, Fujishima Naohito, Tagawa Hiroyuki, Sawada Kenichi, Miura Masato |
| UGT1A1*28 polymorphism in chronic lymphocytic leukemia: the first investigation of the polymorphism in disease susceptibility and its specific cytogenetic abnormalities. Acta haematologica 2014 132 (1): 59-67. Karakosta Maria, Kalotychou Vassiliki, Kostakis Alkiviadis, Pantelias Gabriel, Rombos Ioannis, Kouraklis Gregory, Manola Kalliopi |
| Contribution of UGT1A1 variations to chemotherapy-induced unconjugated hyperbilirubinemia in pediatric leukemia patients. Pediatric research 2016 Apr . Nomura Akitaka, Maruo Yoshihiro, Taga Takashi, Takeuchi Yoshihi |
| Imatinib-induced hyperbilirubinemia with UGT1A1 (*28) promoter polymorphism: first case series in patients with gastrointestinal stromal tumor. Annals of gastroenterology : quarterly publication of the Hellenic Society of Gastroenterology 0 29 (4): 551-556. Saif Muhammad Wasif, Smith Melissa Hennessey, Maloney Antonia, Diasio Robert |
| Influence of UGT1A1 polymorphisms on the outcome of acute myeloid leukemia patients treated with cytarabine-base regimens. Journal of translational medicine 2018 Jul 16 (1): 197. Chen Peng, Zhu Ke-Wei, Zhang Dao-Yu, Yan Han, Liu Han, Liu Yan-Ling, Cao Shan, Zhou Gan, Zeng Hui, Chen Shu-Ping, Zhao Xie-Lan, Yang Jing, Chen Xiao-Pi |
| UGT1A1 genotype influences clinical outcome in patients with intermediate-risk acute myeloid leukemia treated with cytarabine-based chemotherapy. Leukemia 2020 Mar . Díaz-Santa Johana, Rodríguez-Romanos Rocío, Osca Gemma, Pratcorona Marta, Garrido Ana, Coll Rosa, Moret Carla, Escoda Lourdes, Tormo Mar, Heras Inma, Arnan Montse, Vives Susanna, Salamero Olga, Lloveras Natàlia, Bargay Joan, Sampol Antònia, Cruz David, Garcia Antoni, Quiñones Teresa, Esteve Jordi, Sierra Jorge, Gallardo David, |
| Association of Inherited Genetic Factors With Drug-Induced Hepatic Damage Among Children With Acute Lymphoblastic Leukemia. JAMA network open 2022 12 5 (12): e2248803. Yang Wenjian, Karol Seth E, Hoshitsuki Keito, Lee Shawn, Larsen Eric C, Winick Naomi, Carroll William L, Loh Mignon L, Raetz Elizabeth A, Hunger Stephen P, Winter Stuart S, Dunsmore Kimberly P, Devidas Meenakshi, Relling Mary V, Yang Jun |
| Chemotherapy-related hyperbilirubinemia in pediatric acute lymphoblastic leukemia: a genome-wide association study from the AIEOP-BFM ALL study group. Journal of experimental & clinical cancer research : CR 2023 1 42 (1): 21. Junk Stefanie V, Schaeffeler Elke, Zimmermann Martin, Möricke Anja, Beier Rita, Schütte Peter, Fedders Birthe, Alten Julia, Hinze Laura, Klein Norman, Kulozik Andreas, Muckenthaler Martina U, Koehler Rolf, Borkhardt Arndt, Vijayakrishnan Jayaram, Ellinghaus David, Forster Michael, Franke Andre, Wintering Astrid, Kratz Christian P, Schrappe Martin, Schwab Matthias, Houlston Richard S, Cario Gunnar, Stanulla Mart |
- Page last reviewed:Feb 1, 2024
- Content source: